Cue Biopharma, Inc.
CUE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,448 | -$8,482 | -$12,257 | -$9,496 |
| Dep. & Amort. | $79 | $796 | $882 | -$238 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1,263 | $1,338 | $1,562 |
| Change in WC | -$3,617 | $2,966 | $1,824 | -$901 |
| Other Non-Cash | $1,962 | $42 | $41 | $45 |
| Operating Cash Flow | -$9,024 | -$3,415 | -$8,172 | -$9,028 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$27 | -$150 | -$2 |
| Net Acquisitions | $20 | $0 | $0 | $0 |
| Inv. Purchases | -$16,288 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $9,500 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $1 |
| Investing Cash Flow | -$6,768 | -$27 | -$150 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,000 | -$1,000 | -$1,000 | -$999 |
| Stock Issued | $1,001 | $18,798 | $0 | $49 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $18 |
| Financing Cash Flow | $1 | $17,798 | -$1,000 | -$932 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15,791 | $14,356 | -$9,322 | -$9,961 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $27,492 | $13,289 | $22,611 | $32,572 |
| End Cash | $11,701 | $27,645 | $13,289 | $22,611 |
| Free Cash Flow | -$9,024 | -$3,442 | -$8,322 | -$9,030 |